Literature DB >> 15148269

Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients.

Umberto Campia1, Carmine Cardillo, Julio A Panza.   

Abstract

BACKGROUND: The pathogenesis of essential hypertension in blacks may differ from that in whites. In particular, black patients usually present with a salt-sensitive, low-renin form, which in animal models is associated with enhanced activity of endothelin-1 (ET-1). This study aimed to assess whether ethnic differences exist in the vascular activity of ET-1 in normotensive and hypertensive blacks and whites. METHODS AND
RESULTS: Forearm blood flow (FBF) responses to intraarterial infusion of an ET(A) receptor blocker (BQ-123) were analyzed by plethysmography in 37 normotensive patients and 27 hypertensive patients according to race. BQ-123 did not affect FBF in normotensive subjects (P=0.30), whereas it produced significant vasodilation in hypertensive subjects (P<0.001). In normotensives, FBF response to BQ-123 was similar in white (n =22) and black (n =15) patients (P=0.85). In contrast, in hypertensive patients, the vasodilator effect of ET(A) receptor blockade was significantly higher in blacks (n =13) than in whites (n =14) (P=0.01). To rule out differences in smooth muscle reactivity, the effects of race on FBF responses to exogenous ET-1 were analyzed in the hypertensive subgroups. Endothelin-1 induced a significant vasoconstriction in both white (n =7) and black patients (n =5) (both P<0.001), without differences between them (P=0.46). In 8 black hypertensives, the response to selective ET(A) blockade was not modified by nonselective blockade of ET-1 receptors by co-infusion of BQ-123 and BQ-788 (P=0.66).
CONCLUSIONS: Hypertensive blacks have enhanced ET(A)-dependent vasoconstrictor tone, probably related to increased production of ET-1. Given the negative vascular effects of ET-1, this abnormality may contribute to the pathogenesis of hypertension and its complications in black patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148269     DOI: 10.1161/01.CIR.0000130590.24107.D3

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  24 in total

1.  Endothelin-1 response to glucose and insulin among African Americans.

Authors:  Stephanie DeLoach; Yonghong Huan; Constantine Daskalakis; Bonita Falkner
Journal:  J Am Soc Hypertens       Date:  2010-08-21

Review 2.  The future of endothelin-receptor antagonism as treatment for systemic hypertension.

Authors:  Gabriel Vorobiof; Burns C Blaxall; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

Review 3.  Hypertension in African Americans.

Authors:  Nomsa Musemwa; Crystal A Gadegbeku
Journal:  Curr Cardiol Rep       Date:  2017-10-28       Impact factor: 2.931

4.  Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.

Authors:  Nicole B Gabler; Benjamin French; Brian L Strom; Ziyue Liu; Harold I Palevsky; Darren B Taichman; Steven M Kawut; Scott D Halpern
Journal:  Chest       Date:  2011-09-22       Impact factor: 9.410

5.  Differences in vascular nitric oxide and endothelium-derived hyperpolarizing factor bioavailability in blacks and whites.

Authors:  Muhiddin A Ozkor; Ayaz M Rahman; Jonathan R Murrow; Nino Kavtaradze; Ji Lin; Amita Manatunga; Salim Hayek; Arshed A Quyyumi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03-27       Impact factor: 8.311

6.  Anthropometric indexes of obesity and hypertension in elderly from Cuba and Barbados.

Authors:  A Rodrigues Barbosa; D Balduino Munaretti; R Da Silva Coqueiro; A Ferreti Borgatto
Journal:  J Nutr Health Aging       Date:  2011-01       Impact factor: 4.075

Review 7.  Racial disparities in cardiovascular disease risk: mechanisms of vascular dysfunction.

Authors:  R Matthew Brothers; Paul J Fadel; David M Keller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-09       Impact factor: 4.733

8.  Evaluation of racial differences in resting and postprandial endothelial function in postmenopausal women matched for age, fitness and body composition.

Authors:  Damon L Swift; Judith Y Weltman; James T Patrie; Eugene J Barrett; Glenn A Gaesser; Arthur Weltman
Journal:  Ethn Dis       Date:  2013       Impact factor: 1.847

9.  Predictors of improvement in endothelial function after exercise training in a diverse sample of postmenopausal women.

Authors:  Damon L Swift; Judith Y Weltman; James T Patrie; Susan A Saliba; Glenn A Gaesser; Eugene J Barrett; Arthur Weltman
Journal:  J Womens Health (Larchmt)       Date:  2013-12-03       Impact factor: 2.681

10.  Endothelin receptor polymorphisms in the cardiovascular system: potential implications for therapy and screening.

Authors:  Luise Holzhauser; Ronald Zolty
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.